nifedipine has been researched along with Parkinsonian Disorders in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with nifedipine could improve the apomorphine-induced rotation behavior in 6-OHDA-lesioned rats." | 1.38 | L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats. ( Ma, Z; Wang, J; Wang, R; Xie, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, R | 1 |
| Ma, Z | 1 |
| Wang, J | 1 |
| Xie, J | 1 |
1 other study available for nifedipine and Parkinsonian Disorders
| Article | Year |
|---|---|
L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Calcium Channel Blockers; Calcium Channels, L-Type; Dopa | 2012 |